Should You Buy Aphria Inc (TSX:APHA) Stock Before FY 2019 Earnings?

Aphria Inc (TSX:APHA)(NYSE:APHA) just posted disappointing third-quarter results. With shares now on sale, should you be buying ahead of Aphria’s FY 2019 earnings announcement?

woman data analyze

Image source: Getty Images.

In April, Aphria (TSX:APHA)(NYSE:APHA) became the first cannabis company to report quarterly earnings for 2019. Because the company’s fiscal year ends in the summer, the announcement was technically Aphria’s third-quarter result of FY 2019.

The stock market was not impressed. According to Fool contributor Keith Speights, several factors were to blame.

First, Aphria was having trouble keeping up with demand. While this ultimately is a great problem to have, difficulties ramping production quickly hurt the bottom line.

Second, the company experienced what it called “temporary packaging and distribution challenges.” Again, investors should read this as a difficulty keeping up with exploding market demand.

The final hindrance stemmed from a variety of financial charges. During the quarter, Aphria took a big impairment charge related to an earlier acquisition, struggled with higher distribution costs, and fought rising corporate expenditures.

Despite the lacklustre results, shares fell by only 15%. It seems that the market is willing to forgive current woes in the expectation that Aphria will right the ship over the long term.

The next time Aphria will report earnings is on July 31. I’d expect management to do everything possible to execute over the next couple months to deliver a strong quarter.

Now that shares are on sale, should you be buying ahead of a potentially improved FY 2019 earnings announcement?

Here’s what needs to happen

Aphria’s weak third-quarter results clearly surprised most of the market. As mentioned earlier, the main issues include

  • Slow cannabis production growth;
  • Trouble scaling operations; and
  • Unexpected expenses.

If Aphria can’t overcome these challenges, the stock could struggle. If Aphria shows improvement, however, shares could be underpriced. All the company needs to do is show that these problems won’t persist into the 2020 fiscal year.

Can Aphria turn things around before the end of its fiscal year?

It’s going to be difficult

Let’s handle the first item: slow production growth. While cannabis demand has been growing by leaps and bounds, Aphria can’t take advantage, unless it grows enough cannabis to meet that demand.

In contrast to competitors like Village Farms International, Aphria as a company has limited experience growing crops at scale. It’s not surprising to see Aphria struggle to assemble commercial-grade facilities essentially overnight.

Management is already guiding for similar sales levels in Q4 compared to Q3, mainly because its Aphria One expansion doesn’t come online until Q1 of 2020. That means investors likely won’t have any more evidence next quarter that Aphria is on the right track.

The second issue — Aphria’s trouble scaling its support operations — also won’t go away any time soon.

According to Fool contributor Keith Speights, the problem stemmed from ever-evolving packaging regulations. “Aphria had primarily manual processes in place during the last quarter and couldn’t get nearly as much product packaged and shipped as it would have liked,” he wrote this month.

As Tesla has shown, quickly building fully-automated facilities can be extraordinarily difficult. If Elon Musk is having trouble, Aphria will likely face the same fate.

The final issue, unexpected financial expenses, should be your biggest concern.

Many investors are shorting Aphria stock on the belief that it “overpaid for acquisitions in Latin America to enrich company insiders, some of which had financial interests in the acquired companies.”

Already, Aphria has been forced to take a $50 million write-down on its recently acquired Latin America assets. If short-sellers are correct, there could be an additional $150 million in value left to write off.

Stay away

Many cannabis investors will likely jump in at today’s discounted price, but if FY 2019 results don’t correct course, the market could continue to dump Aphria stock.

Given the persistent troubles outlined above, it would be quite a feat for Aphria to execute well. I’m sticking to the sidelines.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

David Gardner owns shares of Tesla. Tom Gardner owns shares of Tesla. The Motley Fool owns shares of Tesla and Village Farms International, Inc. Fool contributor Ryan Vanzo has no position in any stocks mentioned. Tesla is a recommendation of Stock Advisor Canada. Village Farms is a recommendation of Hidden Gems Canada.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Are Cannabis Stocks a Good Buy in March 2023?

Cannabis stocks like Canopy Growth Corp (TSX:WEED) are still being talked about, but are they worth buying?

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Down 26% in a Month, Is Canopy a Buy Today?

Canopy Growth Corp (TSX:WEED) is down 26% in a month. Is it time to start bottom fishing?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

What’s Next for Aurora Cannabis Stock?

Aurora Cannabis stock is down 99% from all-time highs. Is ACB stock a buy, sell, or hold in March 2023?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock: Undervalued Gem or Falling Knife?

Canopy Growth remains a high-risk bet, despite falling 95% from all-time highs. Let's see why you need to avoid WEED…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

3 Things to Know About Canopy Growth Stock After Earnings

A new focus on profitability and sustainability might stop the cash burn at Canopy Growth, so the stock can see…

Read more »

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »